What is CVE-2018-12653?

CVE-2018-12653 is a medium-severity vulnerability in Myadrenalin Adrenalin, classified under Cross-site Scripting. CVSS score: 6.1/10. Published 2019-03-25.

How severe is CVE-2018-12653?

Medium severity. CVSS v3 base score is 6.1 out of 10.

XSS in Myadrenalin Adrenalin

CVE-2018-12653

A Reflected Cross Site Scripting (XSS) vulnerability exists in Adrenalin HRMS 5.4.0. An attacker can input malicious JavaScript code in /RPT/SSRSDynamicEditReports.aspx via 'ReportId' parameter.

Vulnerability class: XSS (Cross-Site Scripting)

EPSS: 0.026 (83.8th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 6.1 (Medium). Vector: CVSS:3.0/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N.

Affected products

Myadrenalin Adrenalin — versions 5.4.0
N/a — versions n/a

Weakness classification (CWE)

CWE-79 — Cross-site Scripting

References

cve@mitre.org
cve@mitre.org (Exploit, Third Party Advisory)
cve@mitre.org

Frequently asked questions

What is CVE-2018-12653?: CVE-2018-12653 is a medium-severity vulnerability in Myadrenalin Adrenalin, classified under Cross-site Scripting. CVSS score: 6.1/10. Published 2019-03-25.
How severe is CVE-2018-12653?: Medium severity. CVSS v3 base score is 6.1 out of 10.